NCT02129751: Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder |
|
|
| Not yet recruiting | 4 | 200 | US | bupropion hydrobromide, Aplenzin, Placebo | Bausch Health Americas, Inc. | Major Depressive Disorder | 11/24 | 11/24 | | |
TTOP, NCT04634071: Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment |
|
|
| Recruiting | 2 | 126 | US | Varenicline, Chantix, Bupropion, Wellbutrin XL, Forfivo XL, Zyban, and Aplenzin, Long-acting nicotine replacement therapy, Transdermal nicotine, Low-intensity counseling, High-intensity counseling, No nicotine replacement therapy, nicotine gum, nicotine losenges, nicotine spray, Nicotine Replacement Products | Joseph Valentino, MD | Smoking Cessation, Cancer, Treatment-Related | 01/26 | 01/26 | | |
